Psychedelic Business Spotlight: August 6, 2021
Another clinic gets approval to conduct MDMA research, and new psychedelic research facilities open in Australia and the U.S., plus two game-changing psilocybin patents.
psychae institute
Australia’s First Psychedelic Research Institute Opens with $40 Million Investment
Psychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.
End of content
End of content